215 related articles for article (PubMed ID: 11955746)
1. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies.
Mundt AJ; Lujan AE; Rotmensch J; Waggoner SE; Yamada SD; Fleming G; Roeske JC
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1330-7. PubMed ID: 11955746
[TBL] [Abstract][Full Text] [Related]
2. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy.
Mundt AJ; Mell LK; Roeske JC
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1354-60. PubMed ID: 12873680
[TBL] [Abstract][Full Text] [Related]
3. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.
Brixey CJ; Roeske JC; Lujan AE; Yamada SD; Rotmensch J; Mundt AJ
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1388-96. PubMed ID: 12459361
[TBL] [Abstract][Full Text] [Related]
4. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies.
Mundt AJ; Roeske JC; Lujan AE; Yamada SD; Waggoner SE; Fleming G; Rotmensch J
Gynecol Oncol; 2001 Sep; 82(3):456-63. PubMed ID: 11520140
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies.
Roeske JC; Lujan A; Rotmensch J; Waggoner SE; Yamada D; Mundt AJ
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1613-21. PubMed ID: 11121668
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy.
Lujan AE; Mundt AJ; Yamada SD; Rotmensch J; Roeske JC
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):516-21. PubMed ID: 12957265
[TBL] [Abstract][Full Text] [Related]
7. A dosimetric planning study comparing intensity-modulated radiotherapy with four-field conformal pelvic radiotherapy for the definitive treatment of cervical carcinoma.
Forrest J; Presutti J; Davidson M; Hamilton P; Kiss A; Thomas G
Clin Oncol (R Coll Radiol); 2012 May; 24(4):e63-70. PubMed ID: 21752614
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study.
Chan P; Yeo I; Perkins G; Fyles A; Milosevic M
Radiat Oncol; 2006 May; 1():13. PubMed ID: 16722546
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric planning study for the prevention of anal complications after post-operative whole pelvic radiotherapy in cervical cancer patients with hemorrhoids.
Baek JG; Kim EC; Kim SK; Jang H
Br J Radiol; 2015; 88(1056):20150223. PubMed ID: 26395671
[TBL] [Abstract][Full Text] [Related]
10. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies.
Salama JK; Mundt AJ; Roeske J; Mehta N
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1170-6. PubMed ID: 16730136
[TBL] [Abstract][Full Text] [Related]
11. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy.
Roeske JC; Bonta D; Mell LK; Lujan AE; Mundt AJ
Radiother Oncol; 2003 Nov; 69(2):201-7. PubMed ID: 14643959
[TBL] [Abstract][Full Text] [Related]
12. The role and strategy of IMRT in radiotherapy of pelvic tumors: Dose escalation and critical organ sparing in prostate cancer.
Liu YM; Shiau CY; Lee ML; Huang PI; Hsieh CM; Chen PH; Lin YH; Wang LW; Yen SH
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1113-23. PubMed ID: 17197126
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies.
Georg P; Georg D; Hillbrand M; Kirisits C; Pötter R
Radiother Oncol; 2006 Jul; 80(1):19-26. PubMed ID: 16766068
[TBL] [Abstract][Full Text] [Related]
14. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer?
Adli M; Mayr NA; Kaiser HS; Skwarchuk MW; Meeks SL; Mardirossian G; Paulino AC; Montebello JF; Gaston RC; Sorosky JI; Buatti JM
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):230-8. PubMed ID: 12909238
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
Ahamad A; D'Souza W; Salehpour M; Iyer R; Tucker SL; Jhingran A; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1117-24. PubMed ID: 15990017
[TBL] [Abstract][Full Text] [Related]
16. Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study.
Hashimoto S; Shibamoto Y; Iwata H; Ogino H; Shibata H; Toshito T; Sugie C; Mizoe JE
J Radiat Res; 2016 Sep; 57(5):524-532. PubMed ID: 27380800
[TBL] [Abstract][Full Text] [Related]
17. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
[No Abstract] [Full Text] [Related]
18. Incorporation of SPECT bone marrow imaging into intensity modulated whole-pelvic radiation therapy treatment planning for gynecologic malignancies.
Roeske JC; Lujan A; Reba RC; Penney BC; Diane Yamada S; Mundt AJ
Radiother Oncol; 2005 Oct; 77(1):11-7. PubMed ID: 16024116
[TBL] [Abstract][Full Text] [Related]
19. A novel conformal arc technique for postoperative whole pelvic radiotherapy for endometrial cancer.
Yang R; Jiang W; Wang J
Int J Gynecol Cancer; 2009 Dec; 19(9):1574-9. PubMed ID: 19955940
[TBL] [Abstract][Full Text] [Related]
20. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]